FDA 483 - Sumitomo Chemical Co., Ltd. - September 06, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Sumitomo Chemical Co., Ltd., an API manufacturer in Anpachi-Gun, Gifu, Japan, revealed significant deficiencies in data integrity, quality unit responsibilities, and certificate of analysis practices. The firm failed to conduct meaningful audit trail reviews for HPLC instruments, improperly delegated critical quality assurance duties, and issued Certificates of Analysis lacking essential information. These issues indicate a lack of adequate controls over manufacturing and quality processes.
ID · 16a1e111-f5ee-4741-889d-4fed4a9f7437